Summary
Twenty-two patients suffering from an obsessive and compulsive disorder (OCD) according to DSM-III-R were investigated by polysomnographic sleep EEG recordings under drug-free conditions and compared to age- and sex-matched healthy controls. Sleep efficiency was significantly lower and wake % SPT was significantly increased in the patient group compared to healthy subjects. Sleep architecture did not differ among the two samples. Especially REM sleep measures, in particular, REM latency did not differ among the groups. No positive correlation was found between sleep variables and rating inventories for obsession and compulsions (Y-BOCS), depression (Hamilton) and anxiety (CAS). A secondary depression did not influence sleep EEG variables. The results of this study contradict the assumption that OCD patients show REM sleep and slow wave sleep abnormalities similar to those shown by patients with primary depression.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ananth J, Pecknold J, Van den Steen N (1981) Double-blind comparative study of clomipramine and amitriptylinc in obsessive neurosis. Prog Neuropsychopharmacol 5:257–262
Baxter LR, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE (1987) Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry 44:211–218
Bender L (1935) Anatomopathological data on personality. Am J Psychiatry 92:325–351
Berger M, Lund R, Bronisch T, von Zerssen D (1983) REM latency in neurotic and endogenous depression and the cholinergic REM induction test. Psychiatry Res 10:113–123
Berger M, Riemann D, Höchli D, Spiegel R (1989) The cholinergic rapid eye movement sleep induction test with RS 86. Arch Gen Psychiatry 46:421–486
Büttner-Westphal H, Hand I (1991) Yale-Brown Obsessive Compulsive Scale, Deutsche Übersetzung und Bearbeitung. Verhaltenstherapie 1:226–233
Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR (1988) Serotonin function in obsessive-compulsive disorder. Arch Gen Psychiatry 45:177–185
Flament MF, Rapoport JL, Berg CJ (1985) Clomipramine treatment of childhood obsessive-compulsive disorder. A doublebblind controlled study. Arch Gen Psychiatry 42:977–983
Flament MF, Rapoport JL, Murphy DL, Berg CJ, Lake CR (1987) Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry 44: 219–225
Fontaine R, Chouinard G (1985) Fluoxetine in the treatment of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatr 9:605–608
Gillin JC, Duncan WC, Murphy DL, Post RM, Wehr TA, Goodwin FK, Wyatt RJ, Bunney WE (1981) Age related changes in sleep in depressed and normal subjects. Psychiatry Res 4:73–78
Gillin JC, Sitaram N, Wehr TA, Duncan W, Post RM, Murphy DL, Mendelson WB, Wyatt RJ, Bunney WE, Jr. (1984) Sleep and affective illness. In: Post RM and Ballenger JC (eds) Neurobiology of mood disorders. Williams and Wilkins, Baltimore
Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS (1989a) Efficacy of fluvoxamine in obsessive-compulsive disorder. Arch Gen Psychiatry 46:36–44
Goodmann WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989b) The Yale-Brown Obsessive Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry 46:1012–1016
Goodmann WK, Price IH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989c) The Yale-Brown Obsessive Compulsive Scale: II. Validity. Arch Gen Psychiatry 46: 1006–1011
Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 47: 577–585
Hobson JA, McCarley RW, Wyzinski PW (1975) Sleep cycle oscillation: Reciprocal discharge by two brain stem neuronal groups. Science 189:55
Hobson JA, Lydic R, Baghdoyan HA (1986) Evolving concepts of sleep cycle generation. Behav Brain Sci 9:371
Hohagen F, Riemann D, Gann H, Berger M (1991) REM sleep in primary and secondary depression. In: Ansseau M, Frenckel v R, Franck G (eds) Biological markers of depression: State of the Art. Excepta Medica, Amsterdam, pp 97–105
Hollander E, De-Caria C, Gully R, Nitescu A, Suckow RF, Gorman JM, Klein DF, Liebowitz MR (1991) Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Res 36:1–17
Insel TR, Gillin JC, Moore A, Mendelson WB, Loewenstein R, Murphy DL (1982) Sleep in obsessive-compulsive disorder. Arch Gen Psychiatry 93:1372–1377
Insel TR, Murphy DL, Cohen RM, Alterman J, Linnoila M, Kilts C (1983) Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 40: 605–612
Insel TR, Müller EA, Gillin JC, Siever LJ, Murphy DL (1984) Biological markers in obsessive-compulsive and affective disorders. J Psychiatr Res 18:407–423
Khanna S (1988) Obsessive-compulsive disorder: is there a frontal lobe dysfunction? Biol Psychiatry 24:602–613
Laplane D, Baulac M, Widlöcher D, Dubois B (1984) Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry 47:377–385
Lauer C, Riemann D, Wiegand M, Berger M (1991) From early to late adulthood: Changes in EEG-sleep of depressed patients and healthy volumteers. Biol Psychiatry 29:979–993
Lauer C, Pollmächer T (1992) On the issue of drug washout prior to polysomnographic studies in depressed patients. Neuropsychopharmacology 6:11–16
Marks IM, Stern RF, Mawson D (1980) Clomipramine and exposure in vivo for obsessive-compulsive rituals. Br J Psychiatry 136:1–25
Montgomery SA (1980) Clomipramine in obsessional neurosis: a placebo-controlled trial. Pharm Med 1:189–192
Murphy DL, Pickar D, Alterman IS (1982) Methods for the quantitative assessment of depressive and manic behavior. In: Burdock EI, Sudilovsky A, Gershon S (eds) Quantitative techniques for the evaluation of the behavior of psychiatric patients. Marcel Dekker, New York, pp 35–392
Pauls LP, Towbin KE, Leckman JF, Zahner GEP, Cohen DJ (1986) Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Arch Gen Psychiatry 43:1180–1182
Perse T, Greist JH, Jefferson JW (1987) Fluvoxamine treatment for obsessive-compulsive disorder. Am J Psychiatry 144: 1543–1548
Price LH, Goodman WK, Charney DS (1987) Treatment of severe obsessive-compulsive disorder with fluvoxamine. Am J Psychiatry 144:1059–1061
Rapoport JL (1988) The neurobiology of obsessive-compulsive disorder. JAMA 260 19:2888–2890
Rapoport JL (1991) Reply to commentaries on “recent advances in obsessive-compulsive disorder”. Neuropsychopharmacology 5:21–22
Rechtschaffen A, Kales A (eds), (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Department of Health, Education, and Welfare, Washington DC
Riemann D, Hohagen F, Bahro M, Berger M (in press) Sleep in Depression: The Influence of age, gender diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86. Eur Arch Psychiatry Clin Neurosc
Robins LN, Helzer JE, Weissmann MM, Orvaschel H, Gruenberg E, Burke JD, Regier DA (1984) Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 41: 317–322
Schilder P (1938) The organic background of obsessions and compulsions. Am J Psychiatry 94:1397–1414
Snaith RP, Baugh SJ, Clayden AD, Husain A, Sipple MA (1982) The clinical anxiety scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 141:518–523
Spitzer RL, Williams JB, Gibbons M (1984) The structured clinical interview for DSM-III-R Biometrics Research Department. New York State Psychiatric Institute, New York
Steriade M, McCarley RW (1990) Brainstem control of wakefulness and sleep. Plenum Press, New York
Swedo SE, Shapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport JL (1989) Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 46:518–523
Thoren P, Asberg M, Cronholm B (1980) Clomipramine treatment of obsessive-compulsive disorder: a controlled clinical trial. Arch Gen Psychiatry 37:1281–1285
Tuke DH (1894) Imperative ideas. Brain 17:179–197
Turner SM, Jacob RG, Beidel DC (1985) Fluoxetine treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 5 (4): 207–212
Walsleben J, Robinson D, Lemus C, Hackshaw R, Norman R, Alvir J (1990) Polysomnographic aspects of obsessive-compulsive disorders. Sleep Res 19:177
Wittchen HU, Zaudig M, Schramm E, Spengler P, Mombour B, Kleig J, Horn R (1988) Strukturiertes klinisches Interview für DSM-III-R (SKID-P). Beltz-Test, Weinheim
Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive-compulsive disorder. Arch Gen Psychiatry 44:946–951
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hohagen, F., Lis, S., Krieger, S. et al. Sleep EEG of patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Nuerosci 243, 273–278 (1994). https://doi.org/10.1007/BF02191585
Issue Date:
DOI: https://doi.org/10.1007/BF02191585